🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The goal of this clinical trial is to evaluate whether hypofractionated who...
Status
Recruiting
Location
Siriraj Hospital
Start Date
2026-08-03
Trial ID
NCT07709650
Treatments Being Tested
The purpose of this study is to determine whether the use of a 3D missing t...
Status
Completed
Location
BC Cancer Agency-Vancouver Island Centre
Start Date
2003-09
Trial ID
NCT00187343
Treatments Being Tested
This study is a prospective cohort clinical trial that aims to investigate ...
Status
Recruiting
Location
The Affiliated Suzhou Hospital of Nanjing Medical University
Start Date
2023-01-16
Trial ID
NCT05872724
This phase II trial studies how well chemotherapy before surgery and radiat...
Status
Active Not Recruiting
Location
University of Arizona Cancer Center-Orange Grove Campus
Start Date
2019-03-12
Trial ID
NCT03493425
In this study the patient will receive either whole brain radiation therapy...
Status
Unknown
Location
Good Samaritan Hospital Medical Center
Start Date
2013-06
Trial ID
NCT01890278
Treatments Being Tested
RATIONALE: New imaging techniques using magnetic resonance imaging give bet...
Status
Terminated
Location
NYU Cancer Institute
Start Date
2009-08
Trial ID
NCT01263821
Treatments Being Tested
Human phenylketonuria (PKU) results from phenylalanine hydroxylase (PAH) de...
Status
Terminated
Location
UPMC Children's Hospital of Pittsburgh
Start Date
2011-10-12
Trial ID
NCT01465100
Nowadays the association between radiotherapy and the anti- Epidermal Growt...
Status
Unknown
Location
Division of Radiotherapy European Institute of Oncology
Start Date
2014-01
Trial ID
NCT03001570
Treatments Being Tested
This phase II trial studies how well nab-paclitaxel and gemcitabine hydroch...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-21
Trial ID
NCT02427841